Are Weight-Loss Injections Safe for Teenagers in India? An Honest Answer
Adolescent GLP-1 use exists, has trial evidence behind it, and is genuinely appropriate for a small number of teenagers with severe obesity. It is also a specialist decision that no online weight-loss service should be making.
ALTRcare Medical Team
Clinical Editorial
The short answer: yes, GLP-1 medicines have been studied in adolescents and produced meaningful results in trials, and they are used internationally for a narrow group of teenagers with severe obesity. But adolescent prescribing sits with a paediatrician or paediatric endocrinologist, under specific criteria, with structured lifestyle support alongside and guardian consent. ALTRcare is an adult service and does not treat anyone under 18. If you are reading this for your teenager, the right next step is a paediatric specialist.
What the evidence actually shows
The main adolescent trial of semaglutide, STEP TEENS, ran for 68 weeks in adolescents aged 12 to 17 with obesity and showed substantial reductions in BMI compared with placebo, alongside improvements in liver enzymes, lipids and quality of life. That is a real result, and it is the basis on which regulators internationally extended approval to adolescents from age 12. Longer-term data in this age group remains limited, which is the honest caveat that goes with it.
Regulatory status in India: verify before acting
Reporting in 2026 indicated that CDSCO cleared semaglutide for adolescents aged 12 and above with body weight over 60 kg, as an addition to diet and activity, while other commentary around the same period described the adolescent pathway as still developing. Do not rely on a blog post for this, including this one. Ask the treating paediatric specialist to confirm the current approved indication and the basis on which they are prescribing.
Who this is actually for
Internationally, adolescent GLP-1 use is aimed at teenagers with obesity by age-specific criteria, usually with an obesity-related complication such as type 2 diabetes, fatty liver, sleep apnoea or significant joint problems, and typically only after structured lifestyle intervention has been tried properly. It is not a route for a teenager who wants to lose a few kilos before an exam year or a wedding, and a clinician who agrees to that is not doing their job.
| Element | Why |
|---|---|
| Paediatric specialist evaluation | Growth, puberty stage and secondary causes must be assessed |
| Age-specific BMI criteria | Adult BMI numbers do not apply to under-18s |
| Screening for complications | Fatty liver, type 2 diabetes, sleep apnoea, blood pressure |
| Structured lifestyle programme in place | Medication supplements this, it does not replace it |
| Eating disorder screening | Essential before any appetite-suppressing medicine in this age group |
| Consent from both teenager and guardian | Ethically and legally required |
| Growth and nutrition monitoring on treatment | Adolescents are still growing; intake cannot simply be minimised |
The risks that are specific to adolescents
- Growth and nutrition. A teenager on an appetite-suppressing medicine still needs protein, calcium, iron and total energy to complete growth. This needs active monitoring, not assumption.
- Eating disorder risk. Adolescence is the peak period of onset. Introducing a medicine that suppresses appetite into a mind already preoccupied with body image can go badly, which is why screening comes first.
- Duration. Obesity is a chronic condition and weight tends to return when treatment stops. Starting at 15 raises questions about years of treatment that nobody can fully answer yet.
- Contraception and pregnancy. These medicines are not for use in pregnancy, and this must be discussed directly and sensitively with adolescent girls.
- Standard side effects, including nausea, vomiting and gallbladder issues, apply here as in adults.
What is genuinely dangerous
Buying a pen for your teenager without a paediatric prescription, sharing an adult family member's pen, or ordering vials online. Adolescent dosing, screening and monitoring are not the same as adult care, and a teenager self-managing an injectable medicine without supervision is the situation most likely to cause harm.
What comes first
For almost every family arriving at this question, the effective interventions have not yet been tried properly: household-level food changes rather than a diet for one child, sleep, daily activity, and screening for the conditions that travel with adolescent obesity. Family-based programmes have better evidence in this age group than anything aimed at the child alone. Medication, where it is appropriate, sits on top of that foundation rather than instead of it.
How to have the conversation
If your teenager raised this themselves, take it seriously rather than dismissing it. Behind the request is usually distress about their body, and that is worth addressing whatever the answer on medication turns out to be. Book a paediatrician appointment, let the doctor talk to your teenager directly, and let the assessment produce the answer rather than the internet.
Key takeaways
- Adolescent trial data for semaglutide exists and shows meaningful BMI reduction over 68 weeks.
- Prescribing for under-18s belongs with a paediatrician or paediatric endocrinologist, not an adult service.
- ALTRcare does not treat anyone under 18.
- Eating disorder screening and growth monitoring are essential in this age group.
- Never share an adult's pen or buy medication online for a teenager.
Frequently asked questions
Can a 16-year-old take Ozempic or Wegovy in India?
Any use in a minor is a paediatric specialist decision under specific criteria, with guardian consent and structured lifestyle support alongside. Confirm the current approved indication with the treating specialist rather than relying on online sources.
Does ALTRcare treat teenagers?
No. ALTRcare is an adult service and does not provide care to anyone under 18. For an adolescent, see a paediatrician or paediatric endocrinologist.
Is it safe for a growing teenager to eat less on these medicines?
Reduced appetite during growth needs active nutritional monitoring, because protein, calcium, iron and total energy requirements remain high. That monitoring is part of why specialist supervision is required.
What should we try before medication?
Household-level food and drink changes, adequate sleep, daily activity, and screening for complications such as fatty liver and prediabetes. Family-based programmes have the strongest evidence in this age group.
My teenager is asking for the injection. What do I say?
Take the underlying distress seriously and book a paediatric appointment rather than saying yes or no yourself. Letting a doctor assess and speak with your teenager directly is more useful than a debate at home.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
